<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2176-6223</journal-id>
<journal-title><![CDATA[Revista Pan-Amazônica de Saúde]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Pan-Amaz Saude]]></abbrev-journal-title>
<issn>2176-6223</issn>
<publisher>
<publisher-name><![CDATA[Instituto Evandro Chagas. Secretaria de Vigilância em Saúde e Ambiente. Ministério da Saúde]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2176-62232010000400007</article-id>
<article-id pub-id-type="doi">10.5123/S2176-62232010000400007</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Quimiotipagem e caracterização fenotípica de Cryptococcus isolados em Belém, Estado do Pará, Brasil]]></article-title>
<article-title xml:lang="en"><![CDATA[Chemotype determination and phenotypic characterization of isolated Cryptococcus from Belém, Pará State, Brazil]]></article-title>
<article-title xml:lang="es"><![CDATA[Quimiotipado y caracterización fenotípica de Cryptococcus aislados en Belém, Estado de Pará, Brasil]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[Fabíola Silveira]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sarmento]]></surname>
<given-names><![CDATA[Dayse Nogueira]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santo]]></surname>
<given-names><![CDATA[Elaine Patrícia Tavares do Espírito]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Silvia Helena Marques da]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidade Federal do Pará Instituto de Ciências Biológicas ]]></institution>
<addr-line><![CDATA[Belém Pará]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Instituto Evandro Chagas/SVS/MS Seção de Bacteriologia e Micologia Laboratório de Micologia]]></institution>
<addr-line><![CDATA[Ananindeua Pará]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2010</year>
</pub-date>
<volume>1</volume>
<numero>4</numero>
<fpage>43</fpage>
<lpage>49</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_arttext&amp;pid=S2176-62232010000400007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_abstract&amp;pid=S2176-62232010000400007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iec.gov.br/scielo.php?script=sci_pdf&amp;pid=S2176-62232010000400007&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[A criptococose é uma infecção fúngica oportunista causada por leveduras do gênero Cryptococcus, principalmente Cryptococcus neoformans e Cryptococcus gattii. Devido ao tropismo pelo sistema nervoso central, a principal manifestação clínica da doença é a meningite criptocócica, que acomete com maior gravidade indivíduos com síndrome da imunodeficiência adquirida. O interesse em aspectos fenotípicos, tais como diâmetro de cápsula, hidrólise de ureia, atividade fenoloxidase, vem aumentando por constituírem a virulência do fungo. O objetivo do presente estudo foi quimiotipar as espécies de Cryptococcus recuperados de 15 casos de meningite criptocócica, caracterizando-os quanto aos aspectos fenotípicos. Sendo assim, leveduras anteriormente identificadas como C. neoformans (n = 15) pelo sistema semiautomatizado API ID 32C, e armazenadas na micoteca do Laboratório de Micologia da Seção de Bacteriologia e Micologia do Instituto Evandro Chagas, foram quimiotipadas em meio canavanina-glicina-azul de bromotimol, e avaliadas quanto ao crescimento a 37º C, sensibilidade à cicloheximida, hidrólise da ureia e atividade da fenoloxidase. A partir da semeadura em meio canavanina-glicina-azul de bromotimol, observamos que 47% (7/15) das leveduras eram Cryptococcus gattii e 53% (8/15) eram Cryptococcus neoformans. Apenas um isolado (1/15; 6,7%) foi capaz de crescer a 37º C, sendo que todos foram sensíveis à cicloheximida, bem como produziram hidrólise da ureia. A atividade da fenoloxidase foi observada em todos os isolados estudados, ocorrendo em até 72 h após a incubação. Neste estudo, o isolamento de Cryptococcus neoformans em casos de meningite criptocócica em Belém, Estado do Pará, Brasil, foi mais frequente. Tanto Cryptococcus neoformans como Cryptococcus gattii apresentaram características fenotípicas típicas, assumindo-se que em nossa região ocorrem isolados virulentos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Cryptococcosis is an opportunistic fungal infection that is caused by yeasts of the genus Cryptococcus, mainly Cryptococcus neoformans and Cryptococcus gattii. Due to their tropism for the central nervous system, the main clinical manifestation of the disease is cryptococcal meningitis, which most severely affects individuals with acquired immunodeficiency syndrome. There is increasing interest in some of the phenotypic aspects of these yeasts, such as capsule diameter, urea hydrolysis, and phenoloxidase activity, because they determine the virulence of the fungus. The objective of this study was to determine the chemotype of the Cryptococcus species that were recovered from 15 cases of cryptococcal meningitis and to characterize their phenotypic features. A group of yeasts that were previously identified as C. neoformans (n = 15) by the semi-automated system API ID 32C and stored in the fungal collection of the Laboratory of Mycology of the Bacteriology and Micology Section on the Instituto Evandro Chagas were chemotyped in canavanine glycine bromothymol blue medium and assessed for their growth at 37º C, cycloheximide sensitivity, urea hydrolysis ability, and phenoloxidase activity. Based on culture in canavanine glycine bromothymol blue medium, we observed that 47% (7/15) of the yeasts were C. gattii and that 53% (8/15) were C. neoformans. Only one isolate (1/15) was able to grow at 37º C; all isolates were sensitive to cycloheximide and could hydrolyze urea. Phenoloxidase activity was observed in all groups, occurring up to 72 h after incubation. In this study, cryptococcal meningitis cases in Belém, Pará State, Brazil, were more commonly caused by C. neoformans. Both C. neoformans and C. gattii exhibited typical phenotypic traits, and it was assumed that, virulent isolates occur in our region.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[La criptococosis es una infección fúngica oportunista causada por levaduras del género Cryptococcus, principalmente Cryptococcus neoformans y Cryptococcus gattii. Debido al tropismo por el sistema nervioso central, la principal manifestación clínica de la enfermedad es la meningitis criptocócica, que acomete con más gravedad a individuos con síndrome da inmunodeficiencia adquirida. El interés en aspectos fenotípicos, tales como el diámetro de la cápsula, la hidrólisis de la urea, la actividad fenoloxidasa, han venido en aumento por constituirse en la virulencia del hongo. El objetivo del presente estudio fue el de quimiotipar las especies de Cryptococcus recuperados de 15 casos de meningitis criptocócica, caracterizándolos con relación a los aspectos fenotípicos. Siendo así, levaduras anteriormente identificadas como C. neoformans (n = 15) por el sistema semiautomatizado API ID 32C, y almacenadas en la micoteca del Laboratorio de Micología de la Sección de Bacteriología y Micología del Instituto Evandro Chagas, fueron quimiotipadas en medio canavanina-glicina-azul de bromotimol, y evaluadas con relación a crecimiento a 37º C, sensibilidad a la cicloheximida, hidrólisis de la urea y actividad de la fenoloxidasa. A partir del sembrado en medio canavanina-glicina-azul de bromotimol, observamos que 47% (7/15) de las levaduras eran de Cryptococcus gattii y 53% (8/15) de Cryptococcus neoformans. Apenas un aislado (1/15; 6,7%) fue capaz de crecer a 37º C, siendo que todos fueron sensibles a la cicloheximida, bien como produjeron hidrólisis de la urea. La actividad de la fenoloxidasa se observó en todos los aislados estudiados, ocurriendo en hasta 72 h después de la incubación. En este estudio el aislado de Cryptococcus neoformans en casos de meningitis criptocócica en la Ciudad Belém, Estado de Pará, Brasil, fue más frecuente. Tanto Cryptococcus neoformans como Cryptococcus gattii presentaron características fenotípicas típicas, asumiéndose que en nuestra región ocurren aislados virulentos.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Cryptococcus neoformans]]></kwd>
<kwd lng="pt"><![CDATA[Cryptococcus gattii]]></kwd>
<kwd lng="pt"><![CDATA[Meningite Criptocócica]]></kwd>
<kwd lng="pt"><![CDATA[Fenotipagem]]></kwd>
<kwd lng="en"><![CDATA[Cryptococcus neoformans]]></kwd>
<kwd lng="en"><![CDATA[Cryptococcus gattii]]></kwd>
<kwd lng="en"><![CDATA[Meningitis]]></kwd>
<kwd lng="en"><![CDATA[Cryptococcal]]></kwd>
<kwd lng="en"><![CDATA[Phenotyping]]></kwd>
<kwd lng="es"><![CDATA[Cryptococcus neoformans]]></kwd>
<kwd lng="es"><![CDATA[Cryptococcus gattii]]></kwd>
<kwd lng="es"><![CDATA[Meningitis Criptocócica]]></kwd>
<kwd lng="es"><![CDATA[Fenotipado]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font size="2" face="Verdana"><b>ARTIGO  ORIGINAL | ORIGINAL ARTICLE | ART&Iacute;CULO ORIGINAL</b></font></p>     <p><font size="2" face="Verdana"><i>&nbsp;</i></font></p>     <p><font size="2" face="Verdana"><b><font size="4"><a name="topo"></a>Quimiotipagem e  caracteriza&ccedil;&atilde;o fenot&iacute;pica de <i>Cryptococcus </i>isolados em Bel&eacute;m, Estado do  Par&aacute;, Brasil</font></b></font></p>     <p>&nbsp;</p>     <p><b><font size="3" face="Verdana">Chemotype determination and phenotypic  characterization of isolated <i>Cryptococcus </i>from Bel&eacute;m, Par&aacute; State, Brazil</font></b></p>     <p>&nbsp;</p>     <p><b><font size="3" face="Verdana">Quimiotipado  y caracterizaci&oacute;n fenot&iacute;pica de <i>Cryptococcus </i>aislados  en Bel&eacute;m, Estado de Par&aacute;,  Brasil</font></b></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"><b>Fab&iacute;ola  Silveira Gomes<sup>I</sup>; Dayse Nogueira Sarmento<sup>I</sup>; Elaine Patr&iacute;cia Tavares do Esp&iacute;rito  Santo<sup>I</sup>; Silvia Helena Marques da Silva<sup>II</sup></b></font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"><sup>I</sup><i>Laborat&oacute;rio  de Micologia, Se&ccedil;&atilde;o de Bacteriologia e Micologia, Instituto Evandro  Chagas/SVS/MS, Ananindeua, Par&aacute;, Brasil. Programa de P&oacute;s-Gradua&ccedil;&atilde;o em Biologia  de Agentes Infecciosos e Parasit&aacute;rios, Instituto de Ci&ecirc;ncias Biol&oacute;gicas, Universidade  Federal do Par&aacute;, Bel&eacute;m, Par&aacute;, Brasil    <br> </i></font><font size="2" face="Verdana"><sup>II</sup><i>Laborat&oacute;rio de Micologia, Se&ccedil;&atilde;o de Bacteriologia e  Micologia, Instituto Evandro Chagas/SVS/MS, Ananindeua, Par&aacute;, Brasil</i></font></p>     <p><font size="2" face="Verdana"><a href="#endereco">Endere&ccedil;o para correspond&ecirc;ncia</a></font><font size="2" face="Verdana"><a href="#endereco"><br /> Correspondence<br /> Direcci&oacute;n para correspondencia</a></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p> <hr size="1" noshade>     <p><font size="2" face="Verdana"><b>RESUMO</b></font></p>     <p><font size="2" face="Verdana">A  criptococose &eacute; uma infec&ccedil;&atilde;o f&uacute;ngica oportunista causada por leveduras do g&ecirc;nero <i>Cryptococcus, </i>principalmente <i>Cryptococcus neoformans </i>e <i>Cryptococcus gattii. </i>Devido ao tropismo  pelo sistema nervoso central, a principal manifesta&ccedil;&atilde;o cl&iacute;nica da doen&ccedil;a &eacute; a  meningite criptoc&oacute;cica, que acomete com maior gravidade indiv&iacute;duos com s&iacute;ndrome  da imunodefici&ecirc;ncia adquirida. O interesse em aspectos fenot&iacute;picos, tais como  di&acirc;metro de c&aacute;psula, hidr&oacute;lise de ureia, atividade fenoloxidase, vem aumentando por  constitu&iacute;rem a virul&ecirc;ncia do fungo. O objetivo do presente estudo foi  quimiotipar as esp&eacute;cies de <i>Cryptococcus </i>recuperados de 15 casos de meningite  criptoc&oacute;cica, caracterizando-os quanto aos aspectos fenot&iacute;picos. Sendo assim,  leveduras anteriormente identificadas como <i>C. neoformans </i>(n = 15) pelo sistema  semiautomatizado API ID 32C,  e armazenadas na micoteca do Laborat&oacute;rio de Micologia da Se&ccedil;&atilde;o de Bacteriologia  e Micologia do Instituto Evandro Chagas, foram quimiotipadas em meio  canavanina-glicina-azul de bromotimol, e avaliadas quanto ao crescimento a 37<sup>o</sup> C, sensibilidade &agrave;  cicloheximida, hidr&oacute;lise da ureia e atividade da fenoloxidase. A partir da  semeadura em meio canavanina-glicina-azul de bromotimol, observamos que 47% (7/15) das leveduras eram  Cryptococcus gattii e 53%  (8/15) eram <i>Cryptococcus neoformans. </i>Apenas um isolado  (1/15; 6,7%) foi  capaz de crescer a 37<sup>o</sup> C, sendo que todos foram sens&iacute;veis &agrave; cicloheximida, bem  como produziram hidr&oacute;lise da ureia. A atividade da fenoloxidase foi observada  em todos os isolados estudados, ocorrendo em at&eacute; 72 h ap&oacute;s a incuba&ccedil;&atilde;o. Neste  estudo, o isolamento de <i>Cryptococcus neoformans </i>em casos de meningite  criptoc&oacute;cica em Bel&eacute;m, Estado do Par&aacute;, Brasil, foi mais frequente. Tanto <i>Cryptococcus  neoformans </i>como <i>Cryptococcus gattii </i>apresentaram caracter&iacute;sticas  fenot&iacute;picas t&iacute;picas, assumindo-se que em nossa regi&atilde;o ocorrem isolados  virulentos.</font></p>     <p><font size="2" face="Verdana"><b>Palavras-chaves: </b><i>Cryptococcus neoformans;  Cryptococcus gattii; </i>Meningite Criptoc&oacute;cica; Fenotipagem.</font></p> <hr size="1" noshade>     <p><font size="2" face="Verdana"><b>ABSTRACT</b></font></p>     <p><font size="2" face="Verdana">Cryptococcosis  is an opportunistic fungal infection that is caused by yeasts of the genus <i>Cryptococcus, </i>mainly <i>Cryptococcus neoformans </i>and <i>Cryptococcus gattii. </i>Due  to their tropism for the central nervous system, the main clinical  manifestation of the disease is cryptococcal meningitis, which most severely  affects individuals with acquired immunodeficiency syndrome. There is  increasing interest in some of the phenotypic aspects of these yeasts, such as  capsule diameter, urea hydrolysis, and phenoloxidase activity, because they  determine the virulence of the fungus. The objective of this study was to  determine the chemotype of the <i>Cryptococcus </i>species that were recovered  from 15 cases of cryptococcal meningitis and to characterize their phenotypic  features. A group of yeasts that were previously identified as <i>C. neoformans </i>(n = 15) by the semi-automated system API ID 32C and stored in the fungal  collection of the Laboratory of Mycology of the Bacteriology and Micology  Section on the Instituto Evandro Chagas were chemotyped in canavanine glycine  bromothymol blue medium and assessed for their growth at 37<sup>o</sup> C, cycloheximide  sensitivity, urea hydrolysis ability, and phenoloxidase activity. Based on  culture in canavanine glycine bromothymol blue medium, we observed that 47%  (7/15) of the yeasts were <i>C. gattii </i>and that 53% (8/15) were <i>C.  neoformans. </i>Only one isolate (1/15) was able to grow at 37<sup>o</sup> C; all isolates  were sensitive to cycloheximide and could hydrolyze urea. Phenoloxidase  activity was observed in all groups, occurring up to 72 h after incubation. In  this study, cryptococcal meningitis cases in Bel&eacute;m, Par&aacute; State, Brazil,  were more commonly caused by <i>C. neoformans. </i>Both <i>C. neoformans </i>and <i>C. gattii </i>exhibited typical phenotypic traits, and it was assumed that,  virulent isolates occur in our region.</font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"><b>Keywords: </b><i>Cryptococcus  neoformans; Cryptococcus gattii; </i>Meningitis,  Cryptococcal; Phenotyping.</font></p> <hr size="1" noshade>     <p><font size="2" face="Verdana"><b>RESUMEN</b></font></p>     <p><font size="2" face="Verdana">La criptococosis es una infecci&oacute;n f&uacute;ngica oportunista causada por  levaduras del g&eacute;nero <i>Cryptococcus, </i>principalmente <i>Cryptococcus neoformans </i>y <i>Cryptococcus gattii. </i>Debido al tropismo  por el sistema nervioso central, la principal manifestaci&oacute;n cl&iacute;nica de la  enfermedad es la meningitis criptoc&oacute;cica, que acomete con m&aacute;s gravedad a  individuos con s&iacute;ndrome da inmunodeficiencia adquirida. El inter&eacute;s en aspectos  fenot&iacute;picos, tales como el di&aacute;metro de la c&aacute;psula, la hidr&oacute;lisis de la urea, la  actividad fenoloxidasa, han venido en aumento por constituirse en la virulencia  del hongo. El objetivo del presente estudio fue el de quimiotipar las especies  de <i>Cryptococcus </i>recuperados de 15 casos de meningitis criptoc&oacute;cica, caracteriz&aacute;ndolos con relaci&oacute;n a los  aspectos fenot&iacute;picos. Siendo as&iacute;, levaduras anteriormente identificadas como <i>C. neoformans </i>(n =  15) por el sistema semiautomatizado API ID 32C, y almacenadas en la  micoteca del Laboratorio de Micolog&iacute;a de la Secci&oacute;n de Bacteriolog&iacute;a y  Micolog&iacute;a del Instituto Evandro Chagas, fueron quimiotipadas en medio canavanina-glicina-azul de bromotimol, y  evaluadas con relaci&oacute;n a crecimiento a 37<sup>o</sup> C, sensibilidad a la cicloheximida, hidr&oacute;lisis de la urea y actividad  de la fenoloxidasa. A partir del sembrado en medio canavanina-glicina-azul de  bromotimol, observamos que 47% (7/15) de las levaduras eran de <i>Cryptococcus gattii </i>y 53%  (8/15) de <i>Cryptococcus neoformans. </i>Apenas un aislado (1/15; 6,7%) fue capaz de crecer a 37<sup>o</sup> C, siendo que todos fueron sensibles a la cicloheximida, bien como  produjeron hidr&oacute;lisis de la urea. La actividad de la fenoloxidasa se observ&oacute; en  todos los aislados estudiados, ocurriendo en hasta 72 h despu&eacute;s de la incubaci&oacute;n. En este estudio el aislado de <i>Cryptococcus neoformans </i>en casos  de meningitis criptoc&oacute;cica en la Ciudad Bel&eacute;m, Estado de Par&aacute;, Brasil, fue m&aacute;s  frecuente. Tanto <i>Cryptococcus neoformans </i>como <i>Cryptococcus gattii </i>presentaron  caracter&iacute;sticas fenot&iacute;picas t&iacute;picas, asumi&eacute;ndose que en nuestra regi&oacute;n ocurren  aislados virulentos.</font></p>     <p><font size="2" face="Verdana"><b>Palabras clave: </b><i>Cryptococcus neoformans; Cryptococcus gattii; </i>Meningitis  Criptoc&oacute;cica; Fenotipado. </font></p> <hr size="1" noshade>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>INTRODU&Ccedil;&Atilde;O</b></font></p>     <p><font size="2" face="Verdana">A  partir das duas &uacute;ltimas d&eacute;cadas do s&eacute;culo XX, principalmente, vem sendo  observado o aumento da frequ&ecirc;ncia e gravidade das infec&ccedil;&otilde;es f&uacute;ngicas,  provavelmente como consequ&ecirc;ncia do aumento de popula&ccedil;&otilde;es de risco, como  indiv&iacute;duos com s&iacute;ndrome da imunodefici&ecirc;ncia adquirida (aids), c&acirc;ncer,  autoimunidades, desnutri&ccedil;&atilde;o, antibioticoterapia de longa dura&ccedil;&atilde;o e portadores  de transplantes, entre outras<sup>1</sup>. As leveduras mais frequentemente  isoladas nestes grupos pertencem aos g&ecirc;neros <i>Candida </i>e <i>Cryptococcus</i><sup>2</sup>.</font></p>     <p><font size="2" face="Verdana"><i>Cryptococcus </i>spp s&atilde;o leveduras capsuladas que se disseminam  amplamente e s&atilde;o mundialmente reconhecidas como importantes pat&oacute;genos f&uacute;ngicos oportunistas, incidindo com maior frequ&ecirc;ncia  sobre indiv&iacute;duos com aids<sup>3</sup>. Embora o g&ecirc;nero <i>Cryptococcus </i>se  constitua de mais de 30 esp&eacute;cies,  somente duas esp&eacute;cies, <i>C. neoformans </i>e <i>C. gattii, </i>s&atilde;o causadoras  de manifesta&ccedil;&otilde;es cl&iacute;nicas mais graves de criptococose<sup>4</sup>. A infec&ccedil;&atilde;o &eacute;  habitualmente adquirida pela inala&ccedil;&atilde;o de prop&aacute;gulos vi&aacute;veis no ambiente. Embora  os pulm&otilde;es sejam o s&iacute;tio prim&aacute;rio da infec&ccedil;&atilde;o, a dissemina&ccedil;&atilde;o pode levar &agrave;  meningoencefalite, que &eacute; a manifesta&ccedil;&atilde;o cl&iacute;nica mais diagnosticada em humanos<sup>5</sup>.  A incid&ecirc;ncia da meningite criptoc&oacute;cica vem diminuindo nos &uacute;ltimos anos devido &agrave;  terapia antirretroviral altamente eficaz; no entanto, a distribui&ccedil;&atilde;o gratuita  da medica&ccedil;&atilde;o &eacute; pouco aplicada mundialmente, contribuindo para a severidade dos  casos<sup>6</sup>.</font></p>     <p><font size="2" face="Verdana"><i>C.  neoformans </i>tem distribui&ccedil;&atilde;o mundial e seus prop&aacute;gulos s&atilde;o  relacionados a excretas de aves e ocos de &aacute;rvores, afetando principalmente  hospedeiros imunocomprometidos<sup>7</sup>. <i>C. gattii </i>causa infec&ccedil;&otilde;es  respirat&oacute;rias e disseminadas, acometendo predominantemente indiv&iacute;duos  imunocompetentes<sup>8</sup>. Classicamente, &eacute; limitado aos tr&oacute;picos e subtr&oacute;picos, sendo comumente isolado de reservat&oacute;rios ambientais,  incluindo <i>Eucalyptus camaldulensis </i>e outras esp&eacute;cies de &aacute;rvores<sup>9</sup>.</font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana">A  virul&ecirc;ncia de <i>C. neoformans </i>e <i>C. gattii </i>est&aacute; associada &agrave; produ&ccedil;&atilde;o  de oxidases e de proteases, bem como a propriedades antifagoc&iacute;ticas dos  polissacar&iacute;deos capsulares<sup>10</sup>. S&atilde;o considerados fatores de virul&ecirc;ncia a  c&aacute;psula, o crescimento a 37<sup>o</sup> C, a  produ&ccedil;&atilde;o de melanina<sup>11</sup> e a atividade urease<sup>12</sup>. Como  primeiro fator  de virul&ecirc;ncia descrito para os agentes, a c&aacute;psula &eacute;  composta de no m&iacute;nimo dois polissacar&iacute;deos, glucuronoxilomanana,  galactoxilomanana e uma pequena propor&ccedil;&atilde;o de manoprote&iacute;nas<sup>13</sup>, que  t&ecirc;m grande n&uacute;mero de efeitos no hospedeiro, tais como ativa&ccedil;&atilde;o e deple&ccedil;&atilde;o do  sistema complemento, reduzida resposta de anticorpos, inibi&ccedil;&atilde;o da migra&ccedil;&atilde;o de  leuc&oacute;citos e da fagocitose<sup>14,15</sup>. A melanina contribui para  virul&ecirc;ncia por conferir resist&ecirc;ncia &agrave;s c&eacute;lulas f&uacute;ngicas contra o ataque das  c&eacute;lulas imunol&oacute;gicas efetoras<sup>16</sup>. A atividade urease tem sido implicada  como fator prim&aacute;rio na patog&ecirc;nese da doen&ccedil;a e sua atividade pode ser esp&eacute;cie  e/ou s&iacute;tio de infec&ccedil;&atilde;o espec&iacute;fica. O interesse em aspectos fenot&iacute;picos, tais  como di&acirc;metro de c&aacute;psula, hidr&oacute;lise de ureia, atividade fenoloxidase, vem  aumentando por constitu&iacute;rem a virul&ecirc;ncia do fungo<sup>17</sup>. O objetivo deste estudo foi  identificar as esp&eacute;cies de <i>Cryptococcus </i>isoladas de 15 casos de  neurocriptococose, caracterizando-as fenotipicamente.</font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>MATERIAIS  E M&Eacute;TODOS</b></font></p>     <p><font size="2" face="Verdana">Leveduras  do g&ecirc;nero <i>Cryptococcus </i>isoladas de pacientes com meningite criptoc&oacute;cica foram  identificadas por quimiotipagem em meio canavanina-glicina-azul de bromotimol  (CGB). A caracteriza&ccedil;&atilde;o fenot&iacute;pica foi obtida mediante an&aacute;lises de crescimento  a 37<sup>o</sup> C, sensibilidade &agrave; cicloheximida, hidr&oacute;lise da ureia e atividade da  fenoloxidase.</font></p>     <p><font size="2" face="Verdana"><b>ISOLADOS  DE <i>CRYPTOCOCCUS</i></b><i></i></font></p>     <p><font size="2" face="Verdana">Foram  estudados 15 isolados  de <i>Cryptococcus </i>recuperados de paciente com meningite criptoc&oacute;cica,  diagnosticados por colora&ccedil;&atilde;o negativa (tinta da China) em amostras de l&iacute;quido  cefalorraquidiano no per&iacute;odo de 2005 a 2009. As amostras de  liquor foram provenientes da rotina laboratorial do Laborat&oacute;rio de Micologia da  Se&ccedil;&atilde;o de Bacteriologia e Micologia (SABMI) do Instituto Evandro Chagas (IEC),  sendo os pacientes admitidos por demanda espont&acirc;nea. Dos pacientes, 53% (8/15) eram do sexo feminino  e 47% (7/15) do  sexo masculino, variando a idade entre 15 e 56 anos. Todos os  isolados foram identificados previamente como <i>C. neoformans </i>pelo sistema  semiautomatizado API ID32C (bio Merieux,  Fran&ccedil;a). Os fungos foram recuperados do esp&eacute;cime cl&iacute;nico e mantidos em &aacute;gar  Sabouraud dextrose 2% (Difco, Detroit, Michigan) a 30<sup>o</sup> C, e,  posteriormente &agrave; recupera&ccedil;&atilde;o e identifica&ccedil;&atilde;o, os isolados f&uacute;ngicos foram  semeados em meio caldo extrato de malte acrescido de 15% de glicerol e  congelados a -70<sup>o</sup> C, compondo atualmente parte da micoteca do Laborat&oacute;rio de  Micologia da SABMI/IEC.</font></p>     <p><font size="2" face="Verdana"><b>INDU&Ccedil;&Atilde;O  DE C&Aacute;PSULA</b></font></p>     <p><font size="2" face="Verdana">Procedeu-se  o ensaio de indu&ccedil;&atilde;o de c&aacute;psula, como descrito por Zaragoza e  Casadevall<sup>18</sup>, para minimizar a interfer&ecirc;ncia do armazenamento e  viabilizar a recupera&ccedil;&atilde;o do principal fator de virul&ecirc;ncia destas leveduras.  Resumidamente, as leveduras foram mantidas em 10 mL de caldo Sabouraud &aacute;cido  (2% dextrose, 1% peptona, pH 5.7) por 24 h sob leve agita&ccedil;&atilde;o (150 rpm).  Posteriormente, foram lavadas com PBS pH 7.2, inoculadas em caldo Sabouraud  dilu&iacute;do dez vezes em &aacute;gua destilada e incubadas a 30<sup>o</sup> C por pelo menos 18 h. Ao final do  ensaio, uma l&acirc;mina de microscopia convencional foi preparada com uma al&iacute;quota de 10 |iL deste cultivo e  uma gota de tinta da China, visualizando-se em microsc&oacute;pio &oacute;tico (Carl Zeiss)  sob aumento de 40 x. Observando-se a presen&ccedil;a de c&aacute;psula espessa, uma al&iacute;quota  da suspens&atilde;o de cada isolado foi semeada em &aacute;gar Sabouraud dextrose 2% (Difco,  Detroit, Michigan), incubando-se a 30<sup>o</sup> C por 24-48 h, sendo ent&atilde;o os  isolados submetidos aos ensaios fenot&iacute;picos.</font></p>     <p><font size="2" face="Verdana"><b>QUIMIOTIPAGEM</b></font></p>     <p><font size="2" face="Verdana">As  esp&eacute;cies de <i>Cryptococcus </i>foram diferenciadas entre <i>C. neoformans </i>e <i>C. gattii </i>com base na utiliza&ccedil;&atilde;o de fonte nitrogenada em meio  L-canavanina-glicina-azul de bromotimol, como descrito por Kwon-Chung et al<sup>19</sup>.</font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana"><b>CRESCIMENTO  A 37<sup>o</sup> C</b></font></p>     <p><font size="2" face="Verdana">Os  isolados foram semeados em &Aacute;gar Sabouraud Dextrose 2% e mantidos a 37<sup>o</sup> C por at&eacute; sete  dias.</font></p>     <p><font size="2" face="Verdana"><b>SENSIBILIDADE  &Agrave; CICLOHEXIMIDA</b></font></p>     <p><font size="2" face="Verdana">Os  isolados foram semeados em &aacute;gar Mycosel (Difco, Detroit, Michigan) e mantidos a 30<sup>o</sup> C por at&eacute; sete dias.</font></p>     <p><font size="2" face="Verdana"><b>ATIVIDADE UREASE</b></font></p>     <p><font size="2" face="Verdana">Atividade  urease foi observada pela ocorr&ecirc;ncia de assimila&ccedil;&atilde;o do composto nitrogenado,  presente no meio ureia de Christensen (peptona 0,1%, glicose 0,1%, NaCl 0,5%, KH<sub>2</sub>PO<sub>4</sub>  0,2%, ureia  2%, vermelho de fenol 0,0012%, &aacute;gar 1,8%), tornando-o alcalino. A rea&ccedil;&atilde;o positiva foi  visualizada pela mudan&ccedil;a de cor do indicador de pH de amarelo para  rosa/vermelho.</font></p>     <p><font size="2" face="Verdana"><b>ATIVIDADE FENOLOXIDASE</b></font></p>     <p><font size="2" face="Verdana">A produ&ccedil;&atilde;o de melanina foi observada a partir da  atividade fenoloxidase dos isolados frente ao extrato de sementes de n&iacute;ger <i>{Guizotia  abyssinica} </i>(sementes de n&iacute;ger 5%, KH<sub>2</sub>PO<sub>4</sub> 0,1%, dextrose 0,1%, creatinina 0,1%, &aacute;gar 1,5%), que cont&eacute;m tirosina e &aacute;cido clorog&ecirc;nico como  substratos, seguindo-se a t&eacute;cnica descrita por Paliwal e Randhawa<sup>20</sup>.</font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>RESULTADOS</b></font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana">Os 15 isolados de <i>Cryptococcus </i>foram identificados por meio de quimiotipagem em meio CGB, observando-se  que 53% (8/15) das leveduras foram identificadas como <i>C. neoformans </i>e  47% (7/15) como <i>C. gattii </i>(<a href="#f1">Figura 1</a>).</font></p>     <p><a name="f1"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/rpas/v1n4/4a07f1.gif" border="0"></p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana">A indu&ccedil;&atilde;o de c&aacute;psula  propiciou a observa&ccedil;&atilde;o do efeito do armazenamento e a viabilidade de  restaura&ccedil;&atilde;o deste fator de virul&ecirc;ncia depois de condi&ccedil;&otilde;es <i>in vitro. </i>O  restabelecimento da caracter&iacute;stica mais b&aacute;sica de virul&ecirc;ncia dos isolados foi  obtido em, no m&aacute;ximo, 24 h ap&oacute;s incuba&ccedil;&atilde;o em caldo Sabouraud dilu&iacute;do. No  momento da recupera&ccedil;&atilde;o dos isolados ap&oacute;s o armazenamento, estes mostravam  &iacute;nfimas c&aacute;psulas, confund&iacute;veis com paredes celulares f&uacute;ngicas espessas. Ao  final do ensaio de indu&ccedil;&atilde;o, observou-se o aparecimento de amplo di&acirc;metro de  c&aacute;psula (<a href="#f2">Figura 2</a>).</font></p>     <p><a name="f2"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/rpas/v1n4/4a07f2.gif" border="0"></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana">No presente estudo, um  isolado (6,7%; 1/15) foi termotolerante &agrave; temperatura de 37<sup>o</sup> C. Quanto &agrave;  sensibilidade &agrave; cicloheximida, todos os isolados foram sens&iacute;veis,  independentemente da esp&eacute;cie (<a href="#t1">Tabela 1</a>). Em rela&ccedil;&atilde;o &agrave; atividade urease, todos  os isolados hidrolisaram a ureia ap&oacute;s 24 h de incuba&ccedil;&atilde;o em meio &aacute;gar ureia de  Christensen, indicando a perman&ecirc;ncia de um importante fator de virul&ecirc;ncia  (<a href="#f3">Figura 3</a>). A atividade fenoloxidase foi observada em todos os isolados com  produ&ccedil;&atilde;o do pigmento acastanhado em meio de semente de N&iacute;ger at&eacute;  72 h ap&oacute;s a incuba&ccedil;&atilde;o  (<a href="#f4">Figura 4</a>). A <a href="#t1">tabela 1</a> resume todos os resultados  obtidos neste estudo.</font></p>     <p><a name="t1" id="t1"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/rpas/v1n4/4a07t1.gif" border="0"></p>     <p>&nbsp;</p>     <p><a name="f3" id="f3"></a></p>     <p>&nbsp;</p>     <p align="center"><img src="/img/revistas/rpas/v1n4/4a07f3.gif" border="0"></p>     <p>&nbsp;</p>     <p><a name="f4" id="f4"></a></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p align="center"><img src="/img/revistas/rpas/v1n4/4a07f4.gif" border="0"></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>DISCUSS&Atilde;O</b></font></p>     <p><font size="2" face="Verdana">O presente estudo identificou <i>C. neoformans </i>e <i>C.  gattii </i>como agentes causadores de meningite criptoc&oacute;cica  (neurocriptococose) na Cidade Bel&eacute;m, Estado do Par&aacute;, Brasil, mediante a  utiliza&ccedil;&atilde;o do meio CGB. Este &eacute; empregado na pr&aacute;tica cl&iacute;nica h&aacute; v&aacute;rios anos,  como ferramenta para identifica&ccedil;&atilde;o das duas principais esp&eacute;cies causadoras de  criptococose, sendo que os poucos resultados falsopositivos estimulam a sua  aplica&ccedil;&atilde;o, relatando-se 100% de efic&aacute;cia e com o grau de concord&acirc;ncia com a  identifica&ccedil;&atilde;o molecular chegando at&eacute; 95,4%<sup>21</sup>. Apesar das esp&eacute;cies <i>C.  curvatus, C. laurentii </i>e <i>C. luteolus </i>tamb&eacute;m utilizarem a glicina e induzirem a mudan&ccedil;a de cor do meio para azul cobalto, a utiliza&ccedil;&atilde;o de outros m&eacute;todos auxiliares como, por exemplo, perfil de produ&ccedil;&atilde;o de melanina associado ao PCR multiplex ou sequenciamento da regi&atilde;o D2 da subunidade 28S do rDNA para isolados com aus&ecirc;ncia/diminui&ccedil;&atilde;o da  produ&ccedil;&atilde;o de melanina elimina completamente a falsa identifica&ccedil;&atilde;o<sup>22</sup>.  No presente estudo, todos os isolados foram submetidos &agrave; identifica&ccedil;&atilde;o  semiautomatizada utilizando API ID32C. Esta &eacute;  baseada na assimila&ccedil;&atilde;o de carboidratos e foi conduzida neste trabalho com a  finalidade, principalmente, de confirmar resultados de cultivo daqueles  isolados que possu&iacute;am c&aacute;psula pouco espessa &agrave; microscopia de luz e morfotipo da col&ocirc;nia n&atilde;o caracter&iacute;stico (aus&ecirc;ncia de  aspecto mucoide).  Apesar da assimila&ccedil;&atilde;o de carboidratos n&atilde;o  permitir a diferencia&ccedil;&atilde;o entre <i>C. neoformans </i>e <i>C. gattii, </i>por  apresentarem estas esp&eacute;cies o mesmo perfil de assimila&ccedil;&atilde;o, p&ocirc;de-se excluir a  presen&ccedil;a de outras leveduras, tais como as do g&ecirc;nero <i>Candida.</i></font></p>     <p><font size="2" face="Verdana">A predomin&acirc;ncia  de <i>C. neoformans </i>(53%) corrobora achados  anteriores, desenvolvidos nesta regi&atilde;o, nos quais se observou maior frequ&ecirc;ncia desta esp&eacute;cie como agente etiol&oacute;gico da criptococose<sup>23</sup> e de  isolamento ambiental<sup>24</sup>. Poucos s&atilde;o os estudos que apresentam dados  sobre distribui&ccedil;&atilde;o de casos de criptococose no Estado do Par&aacute; atualmente.  Dentre estes, em 1999 foi relatada a ocorr&ecirc;ncia de casos de meningite  criptoc&oacute;cica em crian&ccedil;as imunocompetentes<sup>25</sup>. Posteriormente, em  estudo retrospectivo incluindo casos de criptococose ocorridos entre 2003 e  2007, observou-se que a etiologia dos 43 casos admitidos era devida a <i>C.  neoformans </i>(50%) e <i>C. gattii </i>(50%), sendo que o tipo molecular VGII  deste foi indicado  como principal agente causador de criptococose nesta regi&atilde;o, indicando uma  frequ&ecirc;ncia inesperada de casos em crian&ccedil;as imunocompetentes<sup>23</sup>. Estes  resultados estimularam o isolamento do fungo de potenciais fontes de infec&ccedil;&atilde;o  para estes  hospedeiros em Bel&eacute;m<sup>24</sup>. Obteve-se ent&atilde;o o isolamento de <i>C.  neoformans </i>VNI e <i>C. gattii </i>VGII de ocos de &aacute;rvore e gaiolas de aves.  Em rela&ccedil;&atilde;o &agrave; distribui&ccedil;&atilde;o da etiologia da criptococose no Brasil, <i>C.  neoformans </i>sorotipo A &eacute; mais prevalente nas Regi&otilde;es Sul, Sudeste e  Centro-Oeste do pa&iacute;s, enquanto que <i>C. gattii </i>&eacute; um importante pat&oacute;geno na  Regi&atilde;o Nordeste<sup>26</sup>.</font></p>     <p><font size="2" face="Verdana">A despeito da distribui&ccedil;&atilde;o mundial de casos de criptococose  causados por <i>C. neoformans </i>em indiv&iacute;duos imunocomprometidos<sup>27</sup>,  a criptococose <i>gattii </i>&eacute; uma infec&ccedil;&atilde;o f&uacute;ngica que  acomete principalmente indiv&iacute;duos imunocompetentes em regi&otilde;es tropicais e subtropicais<sup>28</sup>,  apresentando, pois, importante relev&acirc;ncia em nossa regi&atilde;o. Sabe-se atualmente que, em algumas localidades, <i>C.  gattii </i>&eacute; reconhecido como um agente end&ecirc;mico causador da criptococose. Por  exemplo, na Ilha de Vancouver (Canad&aacute;) o agente frequentemente acomete tanto indiv&iacute;duos residentes como turistas, onde, no  primeiro surto, foi relatada a ocorr&ecirc;ncia de 200 casos, dos quais 9% foram  fatais<sup>29</sup>. Em regi&otilde;es do noroeste do Pac&iacute;fico, especificamente nos  Estados Unidos da Am&eacute;rica, tais como Calif&oacute;rnia, Idaho, Oregon e Washington, casos foram diagnosticados e alguns foram  sugeridos como importados da Ilha de Vancouver<sup>30</sup>. No Jap&atilde;o, um caso  de criptococoma foi diagnosticado em um paciente n&atilde;o infectado pelo HIV, do qual se isolou <i>C. gattii </i>VGIIa, sugerindo-se a  dispers&atilde;o ambiental deste<sup>31</sup>. Em Atlanta (1992 a 2000) e Houston (1993 a  2000), foram diagnosticados 880 e 611 casos de criptococose, respectivamente,  sugeridos como aut&oacute;ctones; contudo a etiologia dos casos n&atilde;o foi contemplada<sup>32</sup>. Na Am&eacute;rica do Sul,  excluindo-se os relatos de isolamento proveniente de pacientes brasileiros, s&atilde;o  poucos os trabalhos na literatura que versam sobre a distribui&ccedil;&atilde;o de <i>C.  neoformans </i>e <i>C. gattii. </i>P&eacute;rez et al<sup>33</sup>, objetivando  determinar esta distribui&ccedil;&atilde;o, relataram a recupera&ccedil;&atilde;o de 120 (90,9%) isolados  de <i>C. neoformans </i>e 12 (9,1%) de <i>C. gattii </i>advindos de casos  diagnosticados entre 1995 e 2004.</font></p>     <p><font size="2" face="Verdana">Estudos provenientes de variadas regi&otilde;es do mundo v&ecirc;m  descrevendo caracter&iacute;sticas fenot&iacute;picas de <i>C. neoformans </i>e <i>C. gattii, </i>recuperados tanto de esp&eacute;cimes cl&iacute;nicos de pacientes com criptococose<sup>34</sup>  como de materiais derivados do ambiente<sup>35</sup>. Avaliamos a presen&ccedil;a dos  principais fatores de virul&ecirc;ncia associados a <i>C. neoformans </i>e <i>C.  gattii. </i>Resultados da incuba&ccedil;&atilde;o dos isolados  a 37<sup>o</sup> C, demonstraram-nos que apenas um (C. <i>neoformans) </i>apresentou  habilidade de crescer a esta temperatura, indicando a termotoler&acirc;ncia do mesmo.  Isto porque tem-se sugerido que a habilidade de crescimento a 35-37<sup>o</sup> C est&aacute;  diretamente relacionada ao potencial de dissemina&ccedil;&atilde;o do isolado f&uacute;ngico no organismo do hospedeiro mediante a forma&ccedil;&atilde;o de biofilme<sup>36</sup>.</font></p>     <p><font size="2" face="Verdana">A cl&aacute;ssica sensibilidade &agrave; cicloheximida foi observada por todos os isolados, demonstrando a manuten&ccedil;&atilde;o  de uma caracter&iacute;stica intr&iacute;nseca destes fungos. A despeito de achados raros na  literatura, nos quais s&atilde;o relatados isolados at&iacute;picos quanto &agrave; atividade urease<sup>37</sup>,  nossos isolados apresentaram esta atividade em at&eacute; 48 h depois de incubados no  meio de Christensen.</font></p>     <p><font size="2" face="Verdana">A melanina &eacute; um importante fator de virul&ecirc;ncia para leveduras de <i>Cryptococcus</i><sup>38</sup>, relacionada principalmente  ao mecanismo de evas&atilde;o ao sistema imunol&oacute;gico do hospedeiro, dificultando a  fagocitose das leveduras por c&eacute;lulas imunol&oacute;gicas efetoras<sup>16</sup>. Todos os isolados por n&oacute;s analisados  foram capazes de produzir melanina em m&eacute;dia 48 h ap&oacute;s incuba&ccedil;&atilde;o no meio  contendo extrato de N&iacute;ger, indicando a manuten&ccedil;&atilde;o desta propriedade,  considerada como um importante fator de virul&ecirc;ncia de <i>C. neoformans </i>e <i>C.  gattii, </i>mesmo ap&oacute;s o armazenamento por longo per&iacute;odo de tempo.</font></p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>CONCLUS&Atilde;O</b></font></p>     <p><font size="2" face="Verdana">Os m&eacute;todos semiautomatizados  e automatizados atualmente dispon&iacute;veis n&atilde;o permitem a diferencia&ccedil;&atilde;o entre as  duas principais esp&eacute;cies causadoras de criptococose. As esp&eacute;cies <i>C.  neoformans </i>e <i>C. gattii </i>circulantes em Bel&eacute;m s&atilde;o tipicamente virulentas. A partir dos resultados apresentados, foi observado que as  caracter&iacute;sticas t&iacute;picas de leveduras causadoras de meningite criptoc&oacute;cica  permaneceram ativas mesmo ap&oacute;s manuten&ccedil;&atilde;o <i>in vitro. </i>As principais  caracter&iacute;sticas fenot&iacute;picas, tais como presen&ccedil;a de c&aacute;psula, sensibilidade a  cicloheximida, atividade urease e fenoloxidade, estiveram presentes em todos os  isolados analisados.</font></p>     <p>&nbsp;</p>     <p><font size="3" face="Verdana"><b>REFER&Ecirc;NCIAS</b></font></p>     <!-- ref --><p><font size="2" face="Verdana">1 Selik RM, Karon JM, Ward JW. Effect  of the human immunodeficiency virus epidemic on mortality from opportunistic  infections in the United    States in 1993. J Infect Dis. 1997 Sep;176(3):632-6.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pubmed/9291308" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">2 Bava AJ, Robles AM, Negroni R, Arechavala A, Bianchi M. Est&uacute;dio de algunos  aspectos epidemiol&oacute;gicos de 253 casos de criptococosis. Rev Iberoam Micol. 1997;14:111-4.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://reviberoammicol.com/1997-14/111114.pdf" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">3 Chuck SL, Sande MA. Infections with <i>Cryptococcosis neoformans </i>in the acquired  immunodeficiency syndrome.  N Engl  J Med. 1989 Sep;321(12):794-9.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pubmed/2671735" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">4 Kwon-Chung KJ, Boekhout  T, Fell JW, Diaz M. Proposal to conserve the name <i>Cryptococcus gattii </i>against <i>C. hondurianus </i>and <i>C. bacillisporus </i>(Basidiomycota,  Hymenomycetes, Tremellomycetiadae). Taxon.  2002 Nov;51(4):804-6.</font><!-- ref --><p><font size="2" face="Verdana">5 Darz&eacute; C, Lucena R, Gomes I, Melo A. Caracter&iacute;sticas cl&iacute;nicas  laboratoriais de 104 casos de meningoencefalite criptoc&oacute;cica.  Rev Soc  Bras Med Trop. 2000  jan-fev;33(1):21-6.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.scielo.br/pdf/rsbmt/v33n1/v33n1a03.pdf" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">6 Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt  ME, et al. The changing epidemiology of cryptococcosis: an update from  population-based active surveillance in 2 large metropolitan areas, 1992-2000.  Clin Infect Dis. 2003 Mar;36(6):789-94.</font><font size="2" face="verdana"><font size="2" face="verdana"> Doi: 10.1086/368091&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://cid.oxfordjournals.org/content/36/6/789.long" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">7 Laz&eacute;ra  MS, Salmito Cavalcanti MA, Londero AT, Trilles L, Nishikawa MM, Wanke B, et al.  Possible primary ecological niche of <i>Cryptococcus neoformans. </i>Med Mycol.  2000 Oct;38(5):379-83.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pubmed/11092385" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">8 Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect  Dis Clin North Am. 2006 Sep;20(3):507-44.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pubmed/16984867" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">9 Fortes ST, Lazera MS, Nishikawa MM, Macedo RCL, Wanke  B. First isolation of <i>Cryptococcus neoformans </i>var. <i>gattii </i>from a native jungle tree in the Brazilian Amazon rainforest.  Mycoses. 2001 Jul;44(5):137&shy;40. DOI:&nbsp;10.1046/j.1439-0507.2001.00651.x </font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://onlinelibrary.wiley.com/doi/10.1046/j.1439-0507.2001.00651.x/abstract" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">10 Levitz SM, Farrell TP.  Growth inhibition of <i>Cryptococcus neoformans </i>by cultured human  monocytes: role of the capsule, opsonins, the cultured surface, and cytokines.  Infect Immun. 1990 May;58(5):1201-9.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC258610/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">11 Casadevall A, Perfect JR. <i>Cryptococcus neoformans. </i>Washington: American  Society for Microbiology Press; 1998.  541 p.</font><!-- ref --><p><font size="2" face="Verdana">12 Cox GM, Mukherjee J,  Cole GT, Casadevall A, Perfect JR. Urease as a virulence factor in experimental  cryptococcosis. Infect Immun. 2000 Feb;68(2):443-8.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC97161/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">13 Cherniak R, Sundstrom JB.  Polysaccharide antigens of the capsule of <i>Cryptocccus neoformans. </i>Infect  Immun. 1994 May;62(5):1507-12.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC186341/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">14 Macher AM, Bennett JE, Gadek  JE, Frank MM. Complement depletion  in cryptococcal sepsis. J Immunol. 1978 May;120(5):1686-90.</font><!-- ref --><p><font size="2" face="Verdana">15 Zaragoza O, Taborda CP,  Casadevall A. The efficacy of complement mediated phagocytosis of <i>Cryptococcus  neoformans </i>is dependent on the location of C3 in the polysaccharide capsule  and involves both direct and indirect C3-mediated interactions. Euro J  Immnunol. 2003;33(3):1957-67. DOI:10.1002/eji.200323848</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://onlinelibrary.wiley.com/doi/10.1002/eji.200323848/abstract" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">16 Wang Y, Aisen P, Casadevall  A. <i>Cryptococcus neoformans </i>melanin and virulence: mechanism of  action. Infect Immun. 1995 Aug;63(8):3131-6.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC173427/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">17 Buchanan K, Murphy JW.  What makes <i>Cryptococcus neoformans </i>a pathogen? Emerg Infect Dis. 1998 Jan-Mar;4(1):71-83.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2627665/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">18 Zaragoza O, Casadevall A. Experimental modulation  of capsule size in <i>Cryptococcus neoformans. </i>Biol Proced Online. 2004;6:10-5.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC272134/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">19 Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for  separation of <i>Cryptococcus neoformans </i>var. <i>neoformans </i>(serotypes A and D) and <i>Cryptococcus neoformans </i>var. <i>gattii </i>(serotypes  B and C). J Clin Microbiol. 1982 Mar;15(3):535-7. DOI:10.1251/bpo68</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC389900/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">20 Paliwal D, Randhawa HS. Evaluation of a simplified <i>Guizotia  abyssinica </i>seed medium for differentiation of <i>Cryptococcus neoformans. </i>J Clin Microbiol. 1978 Apr;7(4):346-8.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC274965/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">21 Klein KR, Hall L, Deml SM, Rysavy JM, Wohlfiel SL, Wengenack NL. Identification of <i>Cryptococcus  gattii </i>by use of L-canavanine glycine bromothymol blue medium and DNA sequencing. J Clin Microbiol. 2009 Nov;47(11):3669-72. DOI: 10.1128/JCM.01072-09</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772631/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">22 Leal AL, Faganello J,  Bassanesi MC, Vainstein MH. <i>Cryptococcus </i>species identification by multiplex PCR. Med Mycol. 2008 Jun;46(4):377-83. Doi:10.1080/13693780701824429  </font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://informahealthcare.com/doi/abs/10.1080/13693780701824429" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">23 Santos WRA, Meye WR, Wanke B,  Costa SP, Trille LS, Nascimento JL, et al. Primary endemic <i>Cryptococcosis gattii </i>by molecular type VGII in  the state of Par&aacute;, Brazil. Mem Inst  Oswaldo Cruz. 2008 Dec;103(8):813-8. Doi:10.1590/S0074-02762008000800012</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762008000800012&lng=en&nrm=iso&tlng=en" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">24 Costa SPSE, Laz&eacute;ra MS, Santos WRA, Morales BP, Bezerra CCF, Nishikawa  MM, et al. First  isolation of <i>Cryptococcus gattii </i>molecular type VGII and <i>Cryptococcus  neoformans </i>molecular type VNI from environmental sources in the city of Bel&eacute;m,  Par&aacute;, Brazil. Mem Inst Oswaldo Cruz. 2009 Jul;104(4):662-4. Doi:  10.1590/S0074-02762009000400023</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000400023&lng=en&nrm=iso&tlng=en" target="_blank">Links</a> &#93;</font></font><font size="2" face="Verdana">&nbsp;</font><!-- ref --><p><font size="2" face="Verdana">25 Correa MP, Oliveira EC, Duarte RR, Pardal PP, Oliveira FM,  Severo LC. Cryptococcosis  in children in the state of Par&aacute;,   Brazil. Rev Soc  Bras Med Trop. 1999 Sep-Oct;32(5):505-8.</font><font size="2" face="verdana"><font size="2" face="verdana"> Doi: 10.1590/S0037-86821999000500006 &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821999000500006&lng=en&nrm=iso&tlng=en" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">26 Nishikawa MM, Lazera MS,  Barbosa GG, Trilles L, Balassiano BR, Macedo RCL, et al. Serotyping of 467 <i>Cryptococcus  neoformans </i>isolates from clinical and environmental sources in Brazil:  analysis of host and regional patterns. J Clin Microbiol. 2003 Jan;41(1):73-7.</font><font size="2" face="verdana"><font size="2" face="verdana"> Doi:10.1128/JCM.41.1.73-77.2003 &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC149604/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">27 Kwon-Chung  KJ, Bennett JE. Epidemiologic differences between the two varieties of <i>Cryptococcus  neoformans. </i>Am J Epidemiol. 1984 Jul;120(1):123-30.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://aje.oxfordjournals.org/content/120/1/123.short" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">28 Dixit A, Carroll SF, Qureshi ST. <i>Cryptococcus  gattii: </i>an emerging cause of fungal disease in North   America. Interdiscip Perspect Infect Dis. 2009;2009: Article  ID 840452 [13 p.]. Doi:&nbsp;10.1155/2009/840452</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686104/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">29 MacDougall L, Kidd SE, Galanis  E, Mak S, Leslie  MJ, Cieslak PR, et al. Spread of <i>Cryptococcus  gattii </i>in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emer  Infec Dis. 2007 Jan;13(1):42&shy;50.</font><font size="2" face="verdana"><font size="2" face="verdana"> Doi:  10.3201/eid1301.060827&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725832/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">30 Centers for Disease Control and Prevention. Emergence  of <i>Cryptococcus gattii - </i>Pacific  Northwest, 2004-2010. MMWR Morb Mortal Wkly Rep. 2010 Jul;59(28):865-8.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.cdc.gov/mmwr/pdf/wk/mm5928.pdf" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">31 Okamoto K, Hatakeyama S,  Itoyama S, Nukui Y, Yoshino Y, Kitazawa  T, et al. <i>Cryptococcus  gattii </i>genotype VGIIa infection in man, Japan, 2007.  Emer Infec Dis. 2010 Jul;16(7):1155-7. DOI: 10.3201/eid1607.100106 </font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.cdc.gov/eid/content/16/7/1155.htm" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">32 Mirza SA, Phelan M, Rimland  D, Graviss E, Hamill R, Brandt  ME, et al. The changing epidemiology of cryptococcosis: an update from  population-based active surveillance in 2 large metropolitan areas, 1992-2000.  Clin Infect Dis.  2003 Mar;36(6):789-94. Doi:10.1086/368091 </font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://cid.oxfordjournals.org/content/36/6/789.long" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">33 P&eacute;rez C, Dolande M, Moya M, Rosell&oacute; A,  Capriles CR, Landaeta ME, et al. <i>Cryptococcus neoformans,  Cryptococcus gattii: </i>serotypes in Venezuela. Mycopathologia. 2008 Sep;166(3):149-53. DOI:10.1007/s11046-008-9132-1</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.springerlink.com/content/t450tl05l2l40381/" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">34 Favalessa OC, Ribeiro LC, Tadano T, Fontes CJF, Dias FB, Coelho BPA, et  al. First description of phenotypic profile and <i>in  vitro </i>drug susceptibility of <i>Cryptococcus </i>spp yeast isolated from  HIV-positive and HIV-negative patients in State of Mato Grosso. Rev Soc Bras Med Trop. 2009 Dec;42(6):661-5. </font><font size="2" face="verdana"><font size="2" face="verdana">Doi:10.1590/S0037-86822009000600010&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822009000600010&lng=en&nrm=iso&tlng=en" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">35 Hu&eacute;rfano S, Cepero MC, Casta&ntilde;eda E. Caracterizaci&oacute;n fenot&iacute;pica  de aislamientos ambientales de&nbsp; <i>Cryptococcus&nbsp; neoformans. </i>Biom&eacute;dica. 2003 Sep;23(3):328-40.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://redalyc.uaemex.mx/pdf/843/84323310.pdf" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">36 Pettit RK, Repp KK, Hazen KC. Temperature affects the susceptibility  of <i>Cryptococcus neoformans </i>biofilms to antifungal  agents. Med Mycol. 2010 Mar;48(2):421-6.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pubmed/19637092" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">37 Bava AJ, Negroni R, Bianchi M. Cryptococcosis produced  by a urease negative strain of <i>Cryptococcus neoformans. </i>J Med Vet  Mycol. 1993;31(1):87-9.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pubmed/8483060" target="_blank">Links</a> &#93;</font></font><!-- ref --><p><font size="2" face="Verdana">38 Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin  formation as indicators of virulence in <i>Cryptococcus&nbsp; neoformans. </i>Infect Immun. 1986 Jan;51(1):218-23.</font><font size="2" face="verdana"><font size="2" face="verdana">&nbsp;&nbsp; &nbsp; &nbsp; &nbsp;  &nbsp;&#91; <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC261090/?tool=pubmed" target="_blank">Links</a> &#93;</font></font><p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"><b><a name="endereco" id="endereco"></a><a href="#topo"><img src="/img/revistas/rpas/v1n4/seta.gif" border="0" /></a>Correspond&ecirc;ncia / Correspondence  / Correspondencia:</b>    <br> Silvia  Helena Marques da Silva    <br> Laborat&oacute;rio  de Micologia,    <br> Se&ccedil;&atilde;o de Bacteriologia e Micologia,    <br>  Instituto Evandro Chagas    ]]></body>
<body><![CDATA[<br> Rodovia BR 316,   km 7, s/no.    <br> Bairro: Levil&acirc;ndia    <br> CEP: 67030-000    <br> Ananindeua-Par&aacute;-Brasil    <br> Tel.: +55  (91) 3214-2120    <br> E-mail: <a href="mailto:marquespb339@gmail.com">marquespb339@gmail.com</a></font></p>     <p><font size="2" face="Verdana">Recebido em / Received / Recibido en: 10/2/2011    <br> Aceito  em / Accepted / Aceito en: 19/4/2011 </font></p> <script type="text/javascript"> var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); </script> <script type="text/javascript"> try { var pageTracker = _gat._getTracker("UA-7885746-4"); pageTracker._setDomainName("none"); pageTracker._setAllowLinker(true); pageTracker._trackPageview(); } catch(err) {}</script>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Selik]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Karon]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993]]></article-title>
<source><![CDATA[J Infect Dis]]></source>
<year>1997</year>
<month> S</month>
<day>ep</day>
<volume>176</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>632-6</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bava]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Robles]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Negroni]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Arechavala]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bianchi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Estúdio de algunos aspectos epidemiológicos de 253 casos de criptococosis]]></article-title>
<source><![CDATA[Rev Iberoam Micol]]></source>
<year>1997</year>
<volume>14</volume>
<page-range>111-4</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chuck]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Sande]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Infections with Cryptococcosis neoformans in the acquired immunodeficiency syndrome]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1989</year>
<month> S</month>
<day>ep</day>
<volume>321</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>794-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kwon-Chung]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Boekhout]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Fell]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetiadae)]]></article-title>
<source><![CDATA[Taxon]]></source>
<year>2002</year>
<month> N</month>
<day>ov</day>
<volume>51</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>804-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Darzé]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lucena]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Melo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Características clínicas laboratoriais de 104 casos de meningoencefalite criptocócica]]></article-title>
<source><![CDATA[Rev Soc Bras Med Trop]]></source>
<year>2000</year>
<month> j</month>
<day>an</day>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mirza]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Phelan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rimland]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Graviss]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hamill]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2003</year>
<month> M</month>
<day>ar</day>
<volume>36</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>789-94</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lazéra]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Salmito Cavalcanti]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Londero]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
<name>
<surname><![CDATA[Trilles]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Nishikawa]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Wanke]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Possible primary ecological niche of Cryptococcus neoformans]]></article-title>
<source><![CDATA[Med Mycol]]></source>
<year>2000</year>
<month> O</month>
<day>ct</day>
<volume>38</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>379-83</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chayakulkeeree]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Perfect]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cryptococcosis]]></article-title>
<source><![CDATA[Infect Dis Clin North Am]]></source>
<year>2006</year>
<month> S</month>
<day>ep</day>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>507-44</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fortes]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
<name>
<surname><![CDATA[Lazera]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Nishikawa]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Macedo]]></surname>
<given-names><![CDATA[RCL]]></given-names>
</name>
<name>
<surname><![CDATA[Wanke]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[First isolation of Cryptococcus neoformans var. gattii from a native jungle tree in the Brazilian Amazon rainforest]]></article-title>
<source><![CDATA[Mycoses]]></source>
<year>2001</year>
<month> J</month>
<day>ul</day>
<volume>44</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>137­-40</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levitz]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Farrell]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the cultured surface, and cytokines]]></article-title>
<source><![CDATA[Infect Immun]]></source>
<year>1990</year>
<month> M</month>
<day>ay</day>
<volume>58</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1201-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casadevall]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Perfect]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<source><![CDATA[Cryptococcus neoformans]]></source>
<year>1998</year>
<page-range>541</page-range><publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[American Society for Microbiology Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cox]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Mukherjee]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cole]]></surname>
<given-names><![CDATA[GT]]></given-names>
</name>
<name>
<surname><![CDATA[Casadevall]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Perfect]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Urease as a virulence factor in experimental cryptococcosis]]></article-title>
<source><![CDATA[Infect Immun]]></source>
<year>2000</year>
<month> F</month>
<day>eb</day>
<volume>68</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>443-8</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cherniak]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sundstrom]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Polysaccharide antigens of the capsule of Cryptocccus neoformans]]></article-title>
<source><![CDATA[Infect Immun]]></source>
<year>1994</year>
<month> M</month>
<day>ay</day>
<volume>62</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1507-12</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Macher]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Gadek]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Frank]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Complement depletion in cryptococcal sepsis]]></article-title>
<source><![CDATA[J Immunol]]></source>
<year>1978</year>
<month> M</month>
<day>ay</day>
<volume>120</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1686-90</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zaragoza]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Taborda]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Casadevall]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The efficacy of complement mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions]]></article-title>
<source><![CDATA[Euro J Immnunol]]></source>
<year>2003</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1957-67</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Aisen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Casadevall]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cryptococcus neoformans melanin and virulence: mechanism of action]]></article-title>
<source><![CDATA[Infect Immun]]></source>
<year>1995</year>
<month> A</month>
<day>ug</day>
<volume>63</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>3131-6</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buchanan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[What makes Cryptococcus neoformans a pathogen?]]></article-title>
<source><![CDATA[Emerg Infect Dis]]></source>
<year>1998</year>
<month> J</month>
<day>an</day>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>71-83</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zaragoza]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Casadevall]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Experimental modulation of capsule size in Cryptococcus neoformans]]></article-title>
<source><![CDATA[Biol Proced Online]]></source>
<year>2004</year>
<volume>6</volume>
<page-range>10-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kwon-Chung]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Polacheck]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C)]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>1982</year>
<month> M</month>
<day>ar</day>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>535-7</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paliwal]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Randhawa]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Evaluation of a simplified Guizotia abyssinica seed medium for differentiation of Cryptococcus neoformans]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>1978</year>
<month> A</month>
<day>pr</day>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>346-8</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Deml]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Rysavy]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Wohlfiel]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Wengenack]]></surname>
<given-names><![CDATA[NL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Identification of Cryptococcus gattii by use of L-canavanine glycine bromothymol blue medium and DNA sequencing]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>2009</year>
<month> N</month>
<day>ov</day>
<volume>47</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>3669-72</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Faganello]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bassanesi]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Vainstein]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cryptococcus species identification by multiplex PCR]]></article-title>
<source><![CDATA[Med Mycol]]></source>
<year>2008</year>
<month> J</month>
<day>un</day>
<volume>46</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>377-83</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[WRA]]></given-names>
</name>
<name>
<surname><![CDATA[Meye]]></surname>
<given-names><![CDATA[WR]]></given-names>
</name>
<name>
<surname><![CDATA[Wanke]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Trille]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Nascimento]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Pará, Brazil]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>2008</year>
<month> D</month>
<day>ec</day>
<numero>103</numero><numero>8</numero>
<issue>103</issue><issue>8</issue>
<page-range>813-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[SPSE]]></given-names>
</name>
<name>
<surname><![CDATA[Lazéra]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[WRA]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[BP]]></given-names>
</name>
<name>
<surname><![CDATA[Bezerra]]></surname>
<given-names><![CDATA[CCF]]></given-names>
</name>
<name>
<surname><![CDATA[Nishikawa]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[First isolation of Cryptococcus gattii molecular type VGII and Cryptococcus neoformans molecular type VNI from environmental sources in the city of Belém, Pará, Brazil]]></article-title>
<source><![CDATA[Mem Inst Oswaldo Cruz]]></source>
<year>2009</year>
<month> J</month>
<day>ul</day>
<volume>104</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>662-4</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Pardal]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
<name>
<surname><![CDATA[Severo]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cryptococcosis in children in the state of Pará, Brazil]]></article-title>
<source><![CDATA[Rev Soc Bras Med Trop]]></source>
<year>1999</year>
<month> S</month>
<day>ep</day>
<volume>32</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>505-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nishikawa]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Lazera]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
<name>
<surname><![CDATA[Trilles]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Balassiano]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Macedo]]></surname>
<given-names><![CDATA[RCL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>2003</year>
<month> J</month>
<day>an</day>
<volume>41</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>73-7</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kwon-Chung]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Epidemiologic differences between the two varieties of Cryptococcus neoformans]]></article-title>
<source><![CDATA[Am J Epidemiol]]></source>
<year>1984</year>
<month> J</month>
<day>ul</day>
<volume>120</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>123-30</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dixit]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carroll]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Qureshi]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cryptococcus gattii: an emerging cause of fungal disease in North America]]></article-title>
<source><![CDATA[Interdiscip Perspect Infect Dis]]></source>
<year>2009</year>
<volume>2009</volume>
<numero>840452</numero>
<issue>840452</issue>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[MacDougall]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Kidd]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Galanis]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Mak]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Leslie]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cieslak]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA]]></article-title>
<source><![CDATA[Emer Infec Dis]]></source>
<year>2007</year>
<month> J</month>
<day>an</day>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>42-­50</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<collab>Centers for Disease Control and Prevention</collab>
<article-title xml:lang="en"><![CDATA[Emergence of Cryptococcus gattii: Pacific Northwest, 2004-2010]]></article-title>
<source><![CDATA[MMWR Morb Mortal Wkly Rep]]></source>
<year>2010</year>
<month> J</month>
<day>ul</day>
<volume>59</volume>
<numero>28</numero>
<issue>28</issue>
<page-range>865-8</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Okamoto]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hatakeyama]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Itoyama]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nukui]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshino]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kitazawa]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007]]></article-title>
<source><![CDATA[Emer Infec Dis]]></source>
<year>2010</year>
<month> J</month>
<day>ul</day>
<volume>16</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1155-7</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mirza]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Phelan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rimland]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Graviss]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hamill]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000]]></article-title>
<source><![CDATA[Clin Infect Dis]]></source>
<year>2003</year>
<month> M</month>
<day>ar</day>
<volume>36</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>789-94</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dolande]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Moya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Roselló]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Capriles]]></surname>
<given-names><![CDATA[CR]]></given-names>
</name>
<name>
<surname><![CDATA[Landaeta]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela]]></article-title>
<source><![CDATA[Mycopathologia]]></source>
<year>2008</year>
<month> S</month>
<day>ep</day>
<volume>166</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>149-53</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Favalessa]]></surname>
<given-names><![CDATA[OC]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Tadano]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Fontes]]></surname>
<given-names><![CDATA[CJF]]></given-names>
</name>
<name>
<surname><![CDATA[Dias]]></surname>
<given-names><![CDATA[FB]]></given-names>
</name>
<name>
<surname><![CDATA[Coelho]]></surname>
<given-names><![CDATA[BPA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[First description of phenotypic profile and in vitro drug susceptibility of Cryptococcus spp yeast isolated from HIV-positive and HIV-negative patients in State of Mato Grosso]]></article-title>
<source><![CDATA[Rev Soc Bras Med Trop]]></source>
<year>2009</year>
<month> D</month>
<day>ec</day>
<volume>42</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>661-5</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huérfano]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cepero]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Caracterización fenotípica de aislamientos ambientales de Cryptococcus neoformans]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2003</year>
<month> S</month>
<day>ep</day>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>328-40</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pettit]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Repp]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Hazen]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents]]></article-title>
<source><![CDATA[Med Mycol]]></source>
<year>2010</year>
<month> M</month>
<day>ar</day>
<volume>48</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>421-6</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bava]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Negroni]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bianchi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cryptococcosis produced by a urease negative strain of Cryptococcus neoformans]]></article-title>
<source><![CDATA[J Med Vet Mycol]]></source>
<year>1993</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>87-9</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kwon-Chung]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rhodes]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans]]></article-title>
<source><![CDATA[Infect Immun]]></source>
<year>1986</year>
<month> J</month>
<day>an</day>
<volume>51</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>218-23</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
